Norepinephrine transporter -3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment. (Q50800347)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 May 2011

Language	Label	Description	Also known as
English	Norepinephrine transporter -3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment.	scientific article published on 31 May 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21628343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Norepinephrine transporter -3081(A/T) and alpha-2A-adrenergic receptor MspI polymorphisms are associated with cardiovascular side effects of OROS-methylphenidate treatment (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21628343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

0 references

Mark A. Bellgrove

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21628343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Tarrant D.R. Cummins

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21628343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

2

object named as

Bung-Nyun Kim

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21628343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1

object named as

Soo-Churl Cho

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21628343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Jae-Won Kim

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21628343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

language of work or name

0 references

publication date

31 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21628343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Journal of Psychopharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21628343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21628343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21628343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

380-389

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21628343%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Methylphenidate effects on functional outcomes in the Preschoolers with Attention-Deficit/Hyperactivity Disorder Treatment Study (PATS).

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Efficacy and safety of OROS methylphenidate in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled, double-blind, parallel group, dose-escalation study.

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

A new look at the statistical model identification

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Methylphenidate increases cortical excitability via activation of alpha-2 noradrenergic receptors

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: 24-month outcomes of treatment strategies for attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Paradoxical effect of sibutramine on autonomic cardiovascular regulation

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Autonomic control after blockade of the norepinephrine transporter: a model of orthostatic intolerance.

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Association between homozygosity of a G allele of the alpha-2a-adrenergic receptor gene and methylphenidate response in Korean children and adolescents with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Possible association of the alpha-2A-adrenergic receptor gene with response time variability in attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Adrenergic alpha2A receptor gene and response to methylphenidate in attention-deficit/hyperactivity disorder-predominantly inattentive type

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Panic and hypertension: brothers in arms through 5-HT?

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Short-term cardiovascular effects of methylphenidate and adderall

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Progress and promise of attention-deficit hyperactivity disorder pharmacogenetics

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Sudden death and use of stimulant medications in youths.

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Norepinephrine transporter-deficient mice exhibit excessive tachycardia and elevated blood pressure with wakefulness and activity

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

The reliability and validity of Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version- Korean version (K-SADS-PL-K).

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Effects of methylphenidate on working memory functioning in children with attention deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Variations in the alpha2A-adrenergic receptor gene and their functional effects.

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Dopamine-related genotypes and the dose-response effect of methylphenidate on eating in attention-deficit/hyperactivity disorder youths

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Influences of norepinephrine transporter function on the distribution of sympathetic activity in humans.

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Variability within alpha- and beta-adrenoreceptor genes as a predictor of cardiovascular function at rest and in response to mental challenge

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Pharmacogenetics of methylphenidate response in preschoolers with ADHD.

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Association of the adrenergic alpha2A receptor gene with methylphenidate improvement of inattentive symptoms in children and adolescents with attention-deficit/hyperactivity disorder.

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

A C-1291G polymorphism in the alpha2A-adrenergic receptor gene (ADRA2A) promoter is associated with cortisol escape from dexamethasone and elevated glucose levels

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Impulsiveness as a timing disturbance: neurocognitive abnormalities in attention-deficit hyperactivity disorder during temporal processes and normalization with methylphenidate

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Methylphenidate normalises activation and functional connectivity deficits in attention and motivation networks in medication-naïve children with ADHD during a rewarded continuous performance task.

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Phenotypical evidence for a gender difference in cardiac norepinephrine transporter function

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Targeting 160 candidate genes for blood pressure regulation with a genome-wide genotyping array

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Neuropsychopharmacological mechanisms of stimulant drug action in attention-deficit hyperactivity disorder: a review and integration

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Norepinephrine transporter inhibition alters the hemodynamic response to hypergravitation

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Selective impairment in sympathetic vasomotor control with norepinephrine transporter inhibition

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Acute myocardial infarction related to methylphenidate for adult attention deficit disorder

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Cardiovascular effects of methylphenidate in humans are associated with increases of dopamine in brain and of epinephrine in plasma

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Effects of methylphenidate hydrochloride on the cardiovascular system in vivo and in vitro: a safety pharmacology study

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Atomoxetine versus methylphenidate in paediatric outpatients with attention deficit hyperactivity disorder: a randomized, double-blind comparison trial.

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Cardiac safety of methylphenidate versus amphetamine salts in the treatment of ADHD.

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Association of norepinephrine transporter gene with methylphenidate response

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Parent and Teacher Ratings of ADHD Symptoms: Psychometric Properties in a Community-Based Sample

1 reference

https://api.crossref.org/works/10.1177%2F0269881111405356

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50800347&oldid=1889793146"